JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/17.01.25 Stock

Warrant

DE000JL1KNG2

Real-time Bid/Ask 10:03:33 2024-06-19 am EDT
1.71 EUR / 1.91 EUR +5.23% Intraday chart for JP MORGAN/PUT/BECTON DICKINSON AND CO./225/0.1/17.01.25
Current month-14.43%
1 month+1.18%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-19 1.71 -0.58%
24-06-18 1.72 +1.78%
24-06-17 1.69 -2.87%
24-06-14 1.74 +8.75%
24-06-13 1.6 -2.44%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 03:21 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellPUT
Underlying BECTON, DICKINSON AND COMPANY
Issuer J.P. Morgan
WKN JL1KNG
ISINDE000JL1KNG2
Date issued 2023-04-05
Strike 225 $
Maturity 2025-01-17 (212 Days)
Parity 10 : 1
Emission price 1.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.07
Lowest since issue 1.4
Spread 0.2
Spread %10.47%

Company Profile

Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Sector
-
More about the company

Ratings for Becton, Dickinson and Company

Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings

Consensus: Becton, Dickinson and Company

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
233.7 USD
Average target price
279.2 USD
Spread / Average Target
+19.45%
Consensus